首页> 外文期刊>Annals of allergy, asthma, and immunology >Atopic dermatitisReview of comorbidities and therapeutics
【24h】

Atopic dermatitisReview of comorbidities and therapeutics

机译:特应性皮炎合并症和治疗的回顾

获取原文
获取原文并翻译 | 示例
获取外文期刊封面目录资料

摘要

? 2022Atopic dermatitis (AD) is a very common skin disease associated with substantial burdens on patient health and quality of life. Knowledge regarding the pathogenesis of AD has expanded within recent years, leading to novel and efficacious therapeutic agents. Similarly, our knowledge of the impact of AD on patient's mental and physical health has also expanded. This review summarizes updates on the evolution, comorbidities, and therapeutic options of AD. AD is associated with increased cardiovascular risk, allergic diseases, and adverse mental health outcomes. Topical and systemic therapeutics have drastically altered the landscape of AD therapy in recent years.
机译:?2022特应性皮炎(AD)是一种非常常见的皮肤病,对患者的健康和生活质量造成沉重负担。近年来,关于AD发病机制的知识不断扩大,从而产生了新颖有效的治疗药物。同样,我们对AD对患者身心健康影响的了解也有所扩大。本综述总结了AD的演变、合并症和治疗选择的最新进展。 AD与心血管风险增加、过敏性疾病和不良心理健康结局有关。近年来,局部和全身治疗极大地改变了AD治疗的格局。

著录项

获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号